Scienture (SCNX) said Tuesday that it sold its legacy healthcare IT and wholesale operations subsidiaries to Tollo Health for $5 million.
The company divested Integra Pharma Solutions, Bonum Health, and Softell to streamline operations, optimize its portfolio, and accelerate growth in the branded and specialty pharma markets.
Scienture said it plans to use the sale proceeds to facilitate the high-growth commercial and strategic product development activities at its Scienture LLC subsidiary.
Shares of Scienture Holdings were up over 2% in recent trading.
Price: 0.95, Change: +0.02, Percent Change: +2.11
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。